Overview of receptor allosterism

Research output: Contribution to journalArticleResearchpeer-review

Abstract

In addition to the orthosteric site, which recognizes endogenous ligands, most G protein-coupled receptors (GPCRs) possess topographically distinct allosteric sites that can be recognized by small molecules and accessory cellular proteins. Ligand binding to allosteric sites promotes a conformational change in the GPCR that can alter orthosteric ligand affinity and/or efficacy. Moreover, there has been an increase in recent years in the identification of allosteric agonists that can directly activate the receptor in the absence of orthosteric ligand. Allosteric sites are attractive therapeutic targets because they can be exploited to achieve modes of selectivity and signaling that are not attainable by orthosteric means. However, an important challenge in this field remains the quantification of the myriad of possible allosteric effects on binding and signaling events. This unit provides an overview on GPCR allosterism and the different pharmacological approaches to understanding allosteric behaviors. © 2010 by John Wiley & Sons, Inc.

Original languageEnglish
Pages (from-to)1.21-1 - 1.21-34
Number of pages1
JournalCurrent Protocols in Pharmacology
VolumeChapter 1
Issue numberSupp 51
DOIs
Publication statusPublished - Dec 2010

Cite this

@article{9bb6bc27478649b8b24272ee5212c8c5,
title = "Overview of receptor allosterism",
abstract = "In addition to the orthosteric site, which recognizes endogenous ligands, most G protein-coupled receptors (GPCRs) possess topographically distinct allosteric sites that can be recognized by small molecules and accessory cellular proteins. Ligand binding to allosteric sites promotes a conformational change in the GPCR that can alter orthosteric ligand affinity and/or efficacy. Moreover, there has been an increase in recent years in the identification of allosteric agonists that can directly activate the receptor in the absence of orthosteric ligand. Allosteric sites are attractive therapeutic targets because they can be exploited to achieve modes of selectivity and signaling that are not attainable by orthosteric means. However, an important challenge in this field remains the quantification of the myriad of possible allosteric effects on binding and signaling events. This unit provides an overview on GPCR allosterism and the different pharmacological approaches to understanding allosteric behaviors. {\circledC} 2010 by John Wiley & Sons, Inc.",
author = "Karen Gregory and Patrick Sexton and Arthur Christopoulos",
year = "2010",
month = "12",
doi = "10.1002/0471141755.ph0121s51",
language = "English",
volume = "Chapter 1",
pages = "1.21--1 -- 1.21--34",
journal = "Current Protocols in Pharmacology",
issn = "1934-8282",
number = "Supp 51",

}

Overview of receptor allosterism. / Gregory, Karen; Sexton, Patrick; Christopoulos, Arthur.

In: Current Protocols in Pharmacology, Vol. Chapter 1, No. Supp 51, 12.2010, p. 1.21-1 - 1.21-34.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Overview of receptor allosterism

AU - Gregory, Karen

AU - Sexton, Patrick

AU - Christopoulos, Arthur

PY - 2010/12

Y1 - 2010/12

N2 - In addition to the orthosteric site, which recognizes endogenous ligands, most G protein-coupled receptors (GPCRs) possess topographically distinct allosteric sites that can be recognized by small molecules and accessory cellular proteins. Ligand binding to allosteric sites promotes a conformational change in the GPCR that can alter orthosteric ligand affinity and/or efficacy. Moreover, there has been an increase in recent years in the identification of allosteric agonists that can directly activate the receptor in the absence of orthosteric ligand. Allosteric sites are attractive therapeutic targets because they can be exploited to achieve modes of selectivity and signaling that are not attainable by orthosteric means. However, an important challenge in this field remains the quantification of the myriad of possible allosteric effects on binding and signaling events. This unit provides an overview on GPCR allosterism and the different pharmacological approaches to understanding allosteric behaviors. © 2010 by John Wiley & Sons, Inc.

AB - In addition to the orthosteric site, which recognizes endogenous ligands, most G protein-coupled receptors (GPCRs) possess topographically distinct allosteric sites that can be recognized by small molecules and accessory cellular proteins. Ligand binding to allosteric sites promotes a conformational change in the GPCR that can alter orthosteric ligand affinity and/or efficacy. Moreover, there has been an increase in recent years in the identification of allosteric agonists that can directly activate the receptor in the absence of orthosteric ligand. Allosteric sites are attractive therapeutic targets because they can be exploited to achieve modes of selectivity and signaling that are not attainable by orthosteric means. However, an important challenge in this field remains the quantification of the myriad of possible allosteric effects on binding and signaling events. This unit provides an overview on GPCR allosterism and the different pharmacological approaches to understanding allosteric behaviors. © 2010 by John Wiley & Sons, Inc.

UR - http://www.scopus.com/inward/record.url?scp=84857488876&partnerID=8YFLogxK

U2 - 10.1002/0471141755.ph0121s51

DO - 10.1002/0471141755.ph0121s51

M3 - Article

VL - Chapter 1

SP - 1.21-1 - 1.21-34

JO - Current Protocols in Pharmacology

JF - Current Protocols in Pharmacology

SN - 1934-8282

IS - Supp 51

ER -